{"id":"W2571163265","doi":"10.1182/blood.v124.21.5471.5471","title":"Phase I Study of 131-I-Tositumomab Radioimmunotherapy (RIT) in Patients with Relapsed or Residual CD20 Antigen-Expressing B Cell Lymphomas Following Autologous Hematopoietic Stem Cell Transplantation","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Radioimmunotherapy; Medicine; Ibritumomab tiuxetan; CD20; Hematopoietic stem cell transplantation; Transplantation; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; Lymphoma; Oncology; Cancer research; Gastroenterology; Immunology; Monoclonal antibody; Antibody","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586191,0.00175279,0.002647087,0.0004439028,0.0004159572,0.001064201,0.0010332,0.00114851,0.002119833],"category_scores_gemma":[0.0007093439,0.0006451255,0.001506748,0.0005278363,0.001158906,0.0007276922,0.0003647531,0.002877129,0.000919043],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009938532,"about_ca_system_score_gemma":0.001713136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009154541,"about_ca_topic_score_gemma":0.001299335,"domain_scores_codex":[0.9994957,0.0002302755,0.00003166133,0.00008772992,0.00004557966,0.0001088821],"domain_scores_gemma":[0.9993783,0.0000892402,0.0001046514,0.00006650459,0.0000319624,0.0003293882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6226803,0.1457267,0.01644365,0.001132501,0.002101481,0.0006951924,0.0006471318,0.005063494,0.09341934,0.0004518249,0.002860161,0.1087781],"study_design_scores_gemma":[0.3217002,0.6594667,0.01093004,0.00003070767,0.0004936857,0.000343953,0.00005101433,0.00110778,0.004428632,0.00010107,0.001324974,0.00002123102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957242,0.0009881811,0.0004574064,0.0001532921,0.00006338062,0.001592928,0.0002661777,0.00007255827,0.0006818632],"genre_scores_gemma":[0.9935274,0.000907769,0.001080056,0.0003529946,0.0001200136,0.002128011,0.0009942808,0.00002136895,0.0008681153],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002647087,"threshold_uncertainty_score":0.008388638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01309921226614591,"score_gpt":0.2731688981796613,"score_spread":0.2600696859135154,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}